Figure 5.
Inhibition of STAT3 phosphorylation diminishes IL-17 production in response to C. neoformans. Peripheral blood mononuclear cells were pretreated for 30 min with STAT3 phosphorylation inhibitor stattic (2.5μM) and were subjected to stimulation for 3 days with C. neoformans. Changes of the phosphorylated STAT3 (A) and IL-17-producing cells (B, C) were analyzed by flow cytometry assay, and the supernatant IL-17 level (mean ± SE) was evaluated by ELISA (D). Representative data of three individual experiments are shown. ***0.0001<p<0.01, ****p < 0.0001; ns, no significance.